Creating a safe, effective, tolerable oral insulin has become the holy grail of diabetes drug development, and Israel-based Oramed is one of the frontrunners in this race…
http://www.biopharmadive.com/news/orameds-oral-insulin-shines-in-mid-stage-trials/419657/
